For some women with recurrent UTIs, vaginal estrogen is one prevention option that deserves a conversation. Current urology guidelines recommend vaginal estrogen for peri- and postmenopausal women with recurrent UTIs when there is no contraindication.
“Why do I keep getting UTIs now, and why hasn't anyone talked to me about estrogen?”
That is a question I wish more women knew to ask.
What does estrogen have to do with your bladder?
We tend to think of estrogen in terms of periods, hot flashes, or hormone therapy.
But estrogen also affects the tissues in and around your vagina and urinary tract.
As estrogen declines during perimenopause and menopause, vaginal and urinary tissues can become thinner, drier, and more sensitive. The vaginal environment changes too, including changes in the healthy bacteria that normally live there. These changes are part of what clinicians call genitourinary syndrome of menopause, or GSM, which simply describes vaginal, vulvar, sexual, and urinary changes associated with declining hormones.
For some women, the first clue isn't vaginal dryness.
It's UTI after UTI.
So where does vaginal estrogen come in?
Vaginal estrogen is a low-dose estrogen treatment placed in or around the vaginal area, depending on the prescribed product and instructions.
It comes in forms such as creams, tablets or inserts, and rings. Rather than using estrogen throughout the body specifically to prevent UTIs, vaginal estrogen delivers a small amount directly to local tissues.
That distinction matters.
The 2025 AUA/CUA/SUFU recurrent UTI guideline recommends vaginal estrogen for perimenopausal and postmenopausal women with recurrent UTIs when there is no contraindication. The guideline specifically distinguishes it from systemic estrogen, such as estrogen taken orally or through other whole-body hormone therapy, which should not be prescribed specifically for recurrent UTI prevention.
And vaginal estrogen isn't an antibiotic.
It does not treat an active bacterial UTI. The goal is to address menopause-related tissue changes that may be contributing to the pattern and reduce the likelihood of future infections.
MYTH: “If I'm already taking hormone therapy, I shouldn't need vaginal estrogen.”
FACT: Systemic hormone therapy and local vaginal estrogen don't necessarily do the same job.
Someone can be using systemic estrogen and still have vaginal or urinary symptoms. The recurrent UTI guideline notes that vaginal estrogen may still be considered for women already receiving systemic estrogen when appropriate.
That doesn't mean everyone on hormone therapy needs vaginal estrogen. It means “I'm already on estrogen” doesn't automatically close the conversation.
-
Tell your provider when the pattern started. “I've always had UTIs” and “I started getting them after menopause” are two very different pieces of information.
-
Keep track of confirmed infections. Burning, urgency, and frequency can happen with a UTI, but GSM can cause some of those symptoms too. Repeated urinary symptoms deserve a closer look rather than automatically assuming every episode is another infection.
-
Know what “recurrent” means. ACOG describes recurrent UTI as three or more infections within a year or two or more within six months.
-
Ask specifically about local treatment. Instead of only asking, “Do I need hormones?” try asking, “Could menopause-related changes in my vaginal and urinary tissues be contributing to these UTIs?”
-
Your medical history still matters. Vaginal estrogen isn't something to start simply because you read about it online. Your prescriber should consider your symptoms and health history. For people with a history of estrogen-dependent breast cancer, decisions about low-dose vaginal estrogen require an individualized risk-benefit discussion and, in some situations, coordination with oncology.
If UTIs have become a repeated problem during perimenopause or after menopause, especially if you're also noticing vaginal dryness, burning, irritation, pain with sex, urinary urgency, or frequency, it's worth asking whether GSM could be part of the picture.
That conversation isn't about assuming estrogen is the answer.
It's about making sure the hormone-related changes happening to these tissues aren't being overlooked.
Recurrent UTIs may require antibiotics when there is an active bacterial infection, but prevention can involve a different conversation. When hormone-related tissue changes may be contributing, we want patients to understand why vaginal estrogen might be discussed, how local therapy differs from systemic hormone therapy, and what questions to take back to their prescriber rather than treating every urinary symptom as an isolated event.
If UTIs suddenly become a recurring part of life around menopause, don't only ask how to treat the next infection.
Ask why the pattern changed.
If recurrent UTIs have become part of your menopause experience, ask your healthcare provider whether vaginal estrogen is appropriate to discuss for prevention.
